Ab Initio listed on TIA's Pipeline Navigator
TIA pipeline navigator guides researchers along the path to commercialisation.
Ab Initio is pleased to be listed on the Therapeutic Innovation Australia Pipeline Navigator. This resource provides Australian Researchers and companies a resource to find and partner with facilities that aid the drug development pipeline.
About the TIA: The TIA consortium enables and accelerates the translation of research discovery along the therapeutic development pipeline by ensuring world class research infrastructure facilities are accessible to the Australian translational research community. You can learn more about TIA here
About Ab Initio: Ab Initio is an Australian company providing R&D and pharmaceutical manufacturing services for researchers, start-ups, SMEs and large Pharma locally and overseas. We proud ourself in providing unique formulation solutions to challenging products, value adding to our clients IP and fast-tracking a path to clinical translation. You can learn more about Ab Initio Pharma here
